BIONTECH DIAGNOSTICS GMBH

BCR-TYPER

Software programs for medicine and research, namely, for the examination of the immune system based on the sequencing of nucleic acids;Diagnostics preparations for medical purposes; reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits for medical and veterinary purposes, namely, for the examination of the immune system based on the sequencing of nucleic acids;Chemicals used in industry and science, in particular chemical reagents for research purposes except for medical or veterinary purposes as well as reagents and reagent kits for the scientific examination of immune cell samples based on the sequencing of nucleic acids;

BLADDERTYPER

Reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits primarily comprised of diagnostic reagents and assays for testing body fluids and tissue samples for the diagnosis of cancer or tumours derived from cancer, the prevention of cancer and stratification of patients for relevant cancer therapies, all for medical and veterinary purposes; reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits comprising diagnostic reagents for medical and veterinary use, namely, for diagnosing cancer or tumors derived from cancer, preventing cancer and for stratified diagnosis of patients for appropriate cancer therapies;BLADDER TYPER;

CLAUDENTIFY

Pharmaceutical and veterinary preparations for diagnostic purposes; medical preparations for theragnostic and diagnostic purposes; diagnostic test kits for detecting cancer biomarkers in tissue and tissue slides, primarily comprising antibodies and tissue slides; diagnostic test kits primarily consisting of antibodies and tissue slides;Medical and veterinary theragnostic services, in particular in the field of the detection of cancer markers and auto-antibodies; medical and veterinary diagnostic services, in particular in the field of the detection of cancer markers and auto-antibodies;Scientific services and research for medical and veterinary purposes, in particular in the field of the development of the detection of cancer markers and auto-antibodies;

LUNGTYPER

Pharmaceutical preparations for the treatment of carcinosis and veterinary preparations for mammals, excluding humans, for treating carcinosis; Reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits primarily comprised of diagnostic reagents and assays for testing body fluids and tissue samples for the diagnosis of carcinosis, prediction of carcinosis and stratification of patients for relevant carcinosis therapies, all for medical and veterinary diagnostic purposes;Printed matter, namely, newspapers, books, periodical magazines, and journals in the field of carcinosis; secondary packaging made of paper, cardboard; publications in the nature of newspapers, books, periodical magazines and journals in the field of carcinosis; a series of articles printed on cardboard, all in the field of carcinosis; printed package packaging inserts made of paper and package packaging inserts made of paperboards for medical diagnostic kits; printed instructional and teaching materials in the field of carcinosis;LUNG TYPER;

MAMMATYPER

The mark consists of the word MAMMATYPER in stylized lettering.;Reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits primarily comprised of diagnostic reagents and assays for testing body fluids and tissue samples for the diagnosis of breast cancer, prediction of breast cancer and stratification of patients for relevant breast cancer therapies, all for medical and veterinary purposes;MAMMA TYPER;Color is not claimed as a feature of the mark.;Medical and veterinary laboratory testing services relating to the treatment of humans and animals; medical laboratory testing services for the analysis of samples of patients; medical testing services of a medical laboratory relating to the treatment of humans and animals; protein-chemical, DNA, RNA or immunohistochemical testing services for medical purposes, in particular for the diagnosis of breast cancer, prediction of breast cancer and stratification of patients for relevant breast cancer therapies;Analytical laboratory services in the nature of medical and scientific laboratory services; medical and scientific laboratory services; laboratory research in the field of biomarker expression in cancer; laboratory testing and laboratory analysis services in the nature of scientific research in the field of cancer; advisory services relating to laboratory tests in the field of cancer research; laboratory research services relating to pharmaceuticals; clinical science, medical, pharmaceutical, genetic science and biotechnology research and development services; conducting protein-chemical, DNA, RNA or immunohistochemical tests for scientific purposes, in particular for the development of breast cancer therapies and breast cancer therapeutics;